Health Technology Assessment and Market Access
Market access, pricing and reimbursement strategic planning
Evidence gap analysis | Therapeutic positioning | Evidence based analysis (unmeet medical need) | Global Value Dossier (GVD) | Reimbursement dossier and support the submission to HTA agencies | GVD local adaptation | Pre-submission support, including discussion of PICO proposed by HTA agencies | Post-submission support, including assessment discussion with HTA agencies | Assessment of the feasibility of early market access
